It has been suggested that despite the differences in tumour biology the overexpression of YB-1 in nasopharyngeal cancer may also have clinicopathological significance as a predictive biomarker in HNSCC patients (Tay et al, 2009). This evidence concerns the gene YBX1 and nasopharyngeal carcinoma.